Unknown

Dataset Information

0

Searching for the physiological role of glucose-dependent insulinotropic polypeptide.


ABSTRACT: Glucose-dependent insulinotropic polypeptide (GIP) was established as a gut hormone more than 40 years ago, and there is good experimental support for its role as an incretin hormone although deletion of the GIP receptor or the GIP cells or GIP receptor mutations have only minor effects on glucose metabolism. Unlike the related hormone, GLP-1, GIP stimulates the secretion of glucagon, which in healthy individuals may help to stabilize glucose levels, but in people with type 2 diabetes may contribute to glucose intolerance. A role in lipid metabolism is supported by numerous indirect observations and by resistance to diet-induced obesity after deletion of the GIP receptor. However, a clear effect on lipid clearance could not be identified in humans, raising doubt about its importance. The GIP receptor is widely expressed in the body and also appears to be expressed on bone cells, and experimental studies in rodent point to effects on bone metabolism. Recent studies revealed pronounced inhibitory effects of GIP on bone resorption markers in humans and suggest that GIP may be (one of the) gastrointestinal regulators of bone turn-over. In support of this, a loss-of-function GIP receptor mutation in humans is associated with a marked increase in fracture risk. The lack of a reliable GIP receptor antagonist contributes to the uncertainty regarding the physiological role of GIP.

SUBMITTER: Holst JJ 

PROVIDER: S-EPMC4854498 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Searching for the physiological role of glucose-dependent insulinotropic polypeptide.

Holst Jens Juul JJ   Windeløv Johanne Agerlin JA   Boer Geke Aline GA   Pedersen Jens J   Svendsen Berit B   Christensen Mikkel M   Torekov Signe S   Asmar Meena M   Hartmann Bolette B   Nissen Anne A  

Journal of diabetes investigation 20160418


Glucose-dependent insulinotropic polypeptide (GIP) was established as a gut hormone more than 40 years ago, and there is good experimental support for its role as an incretin hormone although deletion of the GIP receptor or the GIP cells or GIP receptor mutations have only minor effects on glucose metabolism. Unlike the related hormone, GLP-1, GIP stimulates the secretion of glucagon, which in healthy individuals may help to stabilize glucose levels, but in people with type 2 diabetes may contri  ...[more]

Similar Datasets

| S-EPMC4931199 | biostudies-literature
| S-EPMC2803629 | biostudies-literature
| S-EPMC6414548 | biostudies-literature
| S-EPMC4308617 | biostudies-literature
| S-EPMC3219957 | biostudies-literature
| S-EPMC4854499 | biostudies-literature
| S-EPMC6973313 | biostudies-literature
2022-11-08 | PXD034803 | Pride
| S-EPMC8298097 | biostudies-literature
| S-EPMC2682676 | biostudies-literature